Patient leaflet - Jivi
B. PACKAGE LEAFLET
Package Leaflet: Information for the user
Jivi 250 IU powder and solvent for solution for injection
Jivi 500 IU powder and solvent for solution for injection
Jivi 1000 IU powder and solvent for solution for injection
Jivi 2000 IU powder and solvent for solution for injection
Jivi 3000 IU powder and solvent for solution for injection
PEGylated B-domain deleted recombinant human coagulation factor VIII (damoctocog alfa pegol)
-
▼ This medicine is subject to additional monitoring. This will allow quick identification of new afetyinformation. You canhelp by reporting anyside effects you may get. See the end ofsection 4 forhow to report side effects.
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
-
– Keep this leaflet. You may need to read it again.
-
– If youhave any further questions, ask your doctor or pharmacist.
-
- This medicinehas been prescribed for you only. Do not pass it on to others. It mayharm them, even if their signs of illness are the same as yours.
-
– If you get any side effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
What is in this leaflet
-
1. What Jivi is and what it is used for
-
2. What you need to know before you use Jivi
-
3. How to use Jivi
-
4. Possible side effects
-
5. How to store Jivi
-
6. Contents of the pack and other information
1. What Jivi is and what it is used for
Jivi contains the active substance damoctocog alfa pegol. It is produced by recombinant technology witout addition of anyhuman- or animal-derived components in the manufacturing process.
Factor VIII is a protein naturally found in the blood thathelps to clot it. The protein in damoctocog alfa pegolhas been modified (pegylated) to prolong its action in the body.
Jivi is used to treat and prevent bleeding in previously treated adults and adolescents aged from 12 years with haemophilia A (hereditary factor VIII deficiency). It is not for use in children younger tan 12 years of age.
2. What you need to know before you use Jivi
Do not use Jivi if you are
- allergic to damoctocog alfa pegol or any of the other ingredients of this medicine (listed in section 6).
- allergic to mouse or hamster proteins.
Warnings and precautions
Talk to your doctor or pharmacist if you have
- tightness in the chest, fall in blood pressure (often shown by feeling dizzy when getting up quickly), itchy nettle-rash, wheezing, feeling sick or faint. These may be signs of a rare severe sudden allergic reaction to this medicine. Stop injecting the product immediately and get medical help at once if this occurs.
- bleeding that is not being controlled with your usual dose of this medicine. Speak with your doctor immediately if this occurs. You may have developed antibodies against factor VIII (inhibitors) or antibodies against polyethylene glycol (PEG). These make Jivi less effective at preventing and controlling bleeding. Your doctor may carry out tests to confirm this and ensure that your Jivi dose provides adequate factor VIII levels. Your doctor may switch you back to your previous factor VIII treatment, if needed.
- previously developed factor VIII inhibitors to a different product.
- heart disease or you are at risk of heart disease.
- to use a central venous access device for this medicine. You may be at risk of device-related complications where the catheter is inserted including:
- local infections
- bacteria in the blood
- a blood clot in the blood vessel
Children
Jivi is not for use in children younger than 12 years of age.
Other medicines and Jivi
Jivi is not known to influence or be influenced by other medicines. Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.
Driving and using machines
Jivi has no influence on your ability to drive and use machines.
Jivi contains sodium
This medicine contains less than 1 mmol (23 mg) sodium per dose, and is therefore considered to be essentially ‘sodium-free’.
3. How to use Jivi
Treatment with Jivi will be started by a doctor who is experienced in the care of patients with haemophilia A. After suitable training patients or carers may be able to give Jivi at home.
Always use this medicine exactly as described in this leaflet and as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. The dose of factor VIII units is measured in International Units (IU).
Treatment of bleeding
To treat a bleed, your doctor will calculate and adjust your dose and how often it should be given, depending on factors such as:
- your weight
- the severity of your haemophilia A
- where the bleeding is and how serious it is
- whether you have inhibitors and how high their level is
- the factor VIII level that is needed.
Prevention of bleeding
To prevent bleeding your doctor will select an appropriate dose and frequency depending on your need:
- 45–60 IU per kg body weight every 5 days or
- 60 IU per kg body weight every 7 days or
- 30–40 IU per kg body weight two times per week.
Laboratory tests
Laboratory tests at suitable intervals help to ensure you always have adequate factor VIII levels. For major surgery in particular, your blood clotting must be closely monitored.
Duration of treatment
Usually Jivi treatment for haemophilia is needed lifelong.
How Jivi is given
Jivi is injected into a vein over 2 to 5 minutes depending on the total volume and your comfort level.
The maximum rate is 2.5 mL per minute. Jivi should be used within 3 hours after reconstitution.
How Jivi is prepared for injection
Use only the components (vial adapter, pre-filled syringe containing solvent and venipuncture set) provided with each package of this medicine. Please contact your doctor if these components cannot be used. Do not use if any component of the package is opened or damaged.
The reconstituted product must be filtered by using the vial adapter before injection to remove any possible particles in the solution.
This medicine must not be mixed with other injections. Do not use solutions that are cloudy or contain visible particles. Follow the
instructions for use
given by your doctor and provided at the end of this leaflet.If you use more Jivi than you should
Tell your doctor if this occurs. No symptoms of overdose have been reported.
If you forget to use Jivi
Inject your next dose immediately and continue at regular intervals as advised by your doctor.
Do not use a double dose to make up for a forgotten dose.
If you stop using Jivi
Do not stop using this medicine without checking with your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most serious side effects are allergic reactions or severe allergic reaction. Stop injecting Jivi immediately and speak to your doctor at once if such reactions occur. The following symptoms could be an early warning of these reactions:
- chest tightness/general feeling of being unwell
- burning and stinging at the application site
- nettle-rash, flushing
- a reduction in blood pressure, which may make you feel faint upon standing
- feeling sick (nausea)
For patients who have received previous treatment with factor VIII (more than 150 days of treatment) inhibitor antibodies (see section 2) may form uncommonly (less than 1 in 100 patients). If this happens your medicine may stop working properly and you may experience persistent bleeding. If this happens, you should contact your doctor immediately.
The following side effects may occur with this medicine:
Very common (may affect more than 1 in 10 people):
- headache
Common (may affect up to 1 in 10 people):
- stomach pain
- nausea, vomiting
- fever
- allergic reactions (may present as hives, generalized urticaria, tightness of the chest, wheezing,
shortness of breath, low blood pressure, for early symptoms see above)
- local reactions at the injection site such as bleeding under the skin, intense itching, swelling, burning sensation, temporary redness
- dizziness
- trouble falling asleep
- cough
- rash, skin reddening
Uncommon (may affect up to 1 in 100 people):
- taste disturbance
- flushing
- itching
Reporting of side effects
If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Jivi
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on labels and cartons. The expiry date refers to the last day of that month.
Store in a refrigerator (2 °C – 8 °C). Do not freeze.
Keep the medicine in its original package in order to protect from light.
This medicine may be stored at room temperature (up to 25 °C) for up to 6 months when you keep it in its outer carton. If you store it at room temperature it expires after 6 months, or the expiry date if this is earlier.
The new expiry date must be noted on the outer carton when the medicine is removed from the refrigerator.
Do not refrigerate the solution after reconstitution. The reconstituted solution must be used within
3 hours.
Do not use this medicine if you notice any particles or the solution is cloudy.
This medicine is for single use only. Any unused solution must be discarded.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist or physician how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Jivi contains
The active substance is PEGylated B-domain deleted recombinant human coagulation factor VIII (damoctocog alfa pegol). Each vial of Jivi contains nominally 250 or 500 or 1000 or 2000 or 3000 IU damoctocog alfa pegol.
The other ingredients are sucrose, histidine, glycine, sodium chloride, calcium chloride dihydrate, polysorbate 80, acetic acid glacial and water for injections.
What Jivi looks like and contents of the pack
Jivi is provided as a powder and solvent for solution for injection. The powder is dry, and white to slightly yellow. The solvent is a clear liquid. After reconstitution the solution is clear.
Each single pack of Jivi contains
- a glass vial of powder
- a pre-filled syringe of solvent
- a separate plunger rod
- a vial adapter
- a venipuncture set
Jivi is available in pack sizes of:
-
– 1 single pack
-
– 1 multipack with 30 single packs